Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Theragen Etex Revenue

Theragen Etex had revenue of 69.26B KRW in the quarter ending June 30, 2026, with 3.64% growth. This brings the company's total for the last twelve months to 275.36B, up 6.13% year-over-year. In the year 2025, Theragen Etex had annual revenue of 271.59B with 8.80% growth. That makes Theragen Etex the 17,264th largest company in the world by revenue and 870th in South Korea.

• Revenue (ttm): 275.36B
• Revenue Growth: +6.13%
• P/S Ratio: 0.27
• Revenue / Employee: 1.36B
• Employees: 202
• Market Cap: 75.20B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Business 257.79B 94.6%
• Health Care and Genome Analysis Business 14.75B 5.4%

By Geography

Chart

• South Korea 268.40B 98.8%
• Overseas 3.18B 1.2%

Fiscal year ended Dec 31, 2025 See the full Theragen Etex breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	271.59B	21.96B	8.80%
Dec 31, 2024	249.63B	33.16B	15.32%
Dec 31, 2023	216.47B	25.70B	13.47%
Dec 31, 2022	190.77B	24.20B	14.53%
Dec 31, 2021	166.57B	23.54B	16.46%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error